Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer

Phase 1

Terminated

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2003-01-27

Last Posted Date: 2014-07-02

Lead Sponsor: Yale University

Registration Number: NCT00002948

Locations: 🇺🇸
Yale Comprehensive Cancer Center, New Haven, Connecticut, United States

Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2009-08-25

Lead Sponsor: Yale University

Target Recruit Count: 28

Registration Number: NCT00004924

Locations: 🇺🇸
Yale Comprehensive Cancer Center, New Haven, Connecticut, United States
🇺🇸
Northwestern Connecticut Oncology-Hematology Associates - Torrington, Torrington, Connecticut, United States

Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2013-07-25

Lead Sponsor: Yale University

Target Recruit Count: 10

Registration Number: NCT00003111

Locations: 🇺🇸
Yale Comprehensive Cancer Center, New Haven, Connecticut, United States

Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder

Phase 1

Completed

Conditions: Premenstrual Syndrome

Interventions: Other: Treatment as usual (TAU)
Drug: Sertraline

First Posted Date: 2002-11-13

Last Posted Date: 2016-01-12

Lead Sponsor: Yale University

Target Recruit Count: 66

Registration Number: NCT00048854

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

Transcranial Magnetic Stimulation (TMS) Treatment for Patients With Persistent Auditory Hallucinations

Not Applicable

Completed

Conditions: Schizophrenia
Hallucinations

First Posted Date: 2002-07-26

Last Posted Date: 2013-08-06

Lead Sponsor: Yale University

Target Recruit Count: 50

Registration Number: NCT00042159

Locations: 🇺🇸
Yale-New Haven Psychiatric Hospital, New Haven, Connecticut, United States

Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial

Phase 3

Completed

Conditions: Intraventricular Hemorrhage (IVH)
Bleeding in the Brain
Prematurity
Very Low Birth Weight Infants

Interventions: Drug: indomethacin
Drug: placebo

First Posted Date: 2002-04-15

Last Posted Date: 2013-03-28

Lead Sponsor: Yale University

Target Recruit Count: 630

Registration Number: NCT00033917

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
🇺🇸
Maine Medical Center, Portland, Maine, United States
🇺🇸
Brown University School of Medicine, Providence, Rhode Island, United States

Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1

Phase 3

Completed

Conditions: Substance-Related Disorders

First Posted Date: 2002-04-08

Last Posted Date: 2017-01-12

Lead Sponsor: Yale University

Target Recruit Count: 561

Registration Number: NCT00032981

Locations: 🇺🇸
Haight Ashbury Free Clinics, San Francisco, California, United States
🇺🇸
Tarzana Treatment Center, Tarzana, California, United States
🇺🇸
CT Renaissance, Inc., Norwalk, Connecticut, United States

and more 3 locations

Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1

Phase 3

Completed

Conditions: Substance-Related Disorders

First Posted Date: 2002-04-08

Last Posted Date: 2017-01-12

Lead Sponsor: Yale University

Target Recruit Count: 422

Registration Number: NCT00032994

Locations: 🇺🇸
Lower Eastside Service Center (LESC), New York, New York, United States
🇺🇸
Willamette Family Treatment Services, Eugene, Oregon, United States
🇺🇸
Changepoint - Cedar Hills Blvd, Portland, Oregon, United States

and more 2 locations

Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1

Phase 2

Completed

Conditions: Heroin Dependence
Substance Abuse, Intravenous
Opioid-Related Disorders

Interventions: Drug: Buprenorphine

First Posted Date: 2001-08-31

Last Posted Date: 2020-06-29

Lead Sponsor: Yale University

Registration Number: NCT00023283

Locations: 🇺🇸
APT Residential Services Division, New Haven, Connecticut, United States

Isocyanate Antigens and T Cells That Cause Asthma

Completed

Conditions: Asthma
Lung Diseases

First Posted Date: 2000-05-26

Last Posted Date: 2014-03-14

Lead Sponsor: Yale University

Registration Number: NCT00005549

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy